Журнал «Современная Наука»

Russian (CIS)English (United Kingdom)
MOSCOW +7(495)-142-86-81

SHRINKLED LUNG SYNDROME

Zakharyan Elena Arkadievna  (Candidate of Medical Sciences Associate Professor of the Department of Internal Medicine No. 1 Federal State Autonomous Educational Institution of Higher Education "Crimean Federal University named after V.I. Vernadsky”, Institute “Medical Academy named after S.I. Georgievsky, Russia, Simferopol city )

Zakirova Elnara Serverovna  (student, Federal State Autonomous Educational Institution of Higher Education "Crimean Federal University named after V.I. Vernadsky”, Institute “Medical Academy named after S.I. Georgievsky, Russia, Simferopol city )

Miroshnikova Ekaterina Dmitrievna  (student, Federal State Autonomous Educational Institution of Higher Education "Crimean Federal University named after V.I. Vernadsky”, Institute “Medical Academy named after S.I. Georgievsky, Russia, Simferopol city )

Slavnikov Alexey Alexandrovich  (student, Federal State Autonomous Educational Institution of Higher Education "Crimean Federal University named after V.I. Vernadsky”, Institute “Medical Academy named after S.I. Georgievsky, Russia, Simferopol city )

Shriveled lung syndrome (FLS) or vanishing lung syndrome is a complication of a systemic autoimmune disease most commonly seen in systemic lupus erythematosus (SLE), but also in Sjögren's syndrome, rheumatoid arthritis, and scleroderma. This syndrome is characterized by shortness of breath, pain in the anterior, lateral part of the chest, radiating to the shoulder, collarbone, neck, and a progressive decrease in lung volume without signs of pleural or interstitial disease on computed tomography (CT) of the chest. This rare disease can be accompanied by severe complications, including severe shortness of breath and, less commonly, respiratory failure. Although shrunken lung syndrome is rare, clinicians should have a high suspicion of FMF in patients with a long history of SLE and worsening dyspnea. Early treatment can be started to help reduce long-term morbidity and mortality and maintain quality of life.

Keywords:shrunken lung syndrome (SSL), systemic lupus erythematosus (SLE), antinuclear antibodies (ANA), pulmonary fibrosis, rituximab

 

Read the full article …



Citation link:
Zakharyan E. A., Zakirova E. S., Miroshnikova E. D., Slavnikov A. A. SHRINKLED LUNG SYNDROME // Современная наука: актуальные проблемы теории и практики. Серия: Естественные и Технические Науки. -2023. -№03. -С. 166-169 DOI 10.37882/2223–2966.2023.03.14
LEGAL INFORMATION:
Reproduction of materials is permitted only for non-commercial purposes with reference to the original publication. Protected by the laws of the Russian Federation. Any violations of the law are prosecuted.
© ООО "Научные технологии"